|
Daehan New Pharm achieved sales of 66.8 billion won and operating profit of 10.8 billion won in the first half of the year
2019.08.12
|
|---|
|
In the first half of 2019, Daehan New Pharm achieved sales of 66.8 billion won, marking an 8.6% increase compared to the same period the previous year. Operating profit rose 14.5% to 10.8 billion won, and net profit turned positive, reaching 6.6 billion won.
Overall performance improved due to company-wide enhancements in sales efficiency and increased revenue from new product launches, while steady sales continued for existing key products.
Steady profits were also generated in the core sectors of obesity and well-being pharmaceuticals, with strong sales expected in the second half of the year. The company plans to maximize performance through visionary management strategies and strengthening its new product portfolio.
Financial structure improvements initiated last year and favorable reception of new products contributed to the improved results. The company aims to maintain operational efficiency and continue launching new products to sustain positive momentum throughout the second half. |


Home